Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome, supporting a bullish outlook. KYTX's Miv-cel achieved significant clinical improvements and ...
WASHINGTON — A defense policy bill expected to be voted on this week does not include provisions that would have ensured the military’s ability to purchase the technical data, parts and information ...
Hosted on MSN
Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced plans to showcase updated clinical data on its investigational CD19-CAR T cell therapy, resecabtagene autoleucel (rese-cel), during two ...
Shares of CRISPR Therapeutics CRSP were up 3.7% yesterday after the company announced encouraging updates from ongoing studies on its next-generation CAR-T therapy candidate, zugocaptagene geleucel or ...
Follow ZDNET: Add us as a preferred source on Google. Can you believe that the first Roku device launched 17 years ago? It was initially developed in partnership with Netflix to stream its "Watch ...
The Terrain Commander from Textron Corporation provides the basis for the U.S. Army's unattended ground sensor (UGS) Future Combat Systems. The sensor assembly is equipped with a variety of optical, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback